Notifications
Single-Photon Emission Computed Tomography Market Insights:
In a recent research report by Market Research Community, the single-photon emission computed tomography market is expected to surpass USD 4.54 Billion by the year 2030, from USD 2.51 Billion in 2021.
A single-photon emission computed tomography (SPECT) is an imaging scan that aids doctors in analyzing the body's tissues, organs, and bones. A SPECT scan is also called the nuclear imaging test due to the usage of radioactive substances and the special gamma camera for the creation of 3D images.
Neurology is projected to support the increased growth of the application segment during the forecast period owing to the precise planning of therapeutic interventions with the help of activity patterns observed through gamma rays and effectively addressing the structures of neurological clinical conditions such as dementia, tumors, stroke, and others.
Asia-Pacific is expected to have the second largest market share to the augmented growth of the single-photon emission computed tomography market in the projected period. The factors such as the rising spending on the development of healthcare infrastructure and increased cases of chronic diseases among geriatric pollution which is highly susceptible to the need for surgical intervention for treatment are the major contributors to the single-photon emission computed tomography market growth in Asia Pacific region.
The market is projected to grow at a significant pace reaching a CAGR of approximately 6.8%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of the pandemic spread and lockdown restrictions imposed globally.
The study is consolidated into major segments and further into sub-segments, such as by type (hybrid SPECT systems, standalone SPECT systems), by application (oncology, cardiology, and neurology), by end-use (hospitals, and diagnostic imaging centers), to Single-Photon Emission Computed Tomography Market forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including GE Healthcare, Siemens Healthcare, Mediso Ltd., Koninklijke Philips N.V., Bruker Corporation, Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America Inc., CardiArc
Contact: